[Eosinophilic esophagitis: a rare cause of dysphagia].

Rev Med Interne

Service des maladies digestives, hôpital d'instruction des armées Legouest, 27, avenue de Plantières, BP 90001, 57077 Metz cedex 3, France.

Published: December 2010

AI Article Synopsis

  • Eosinophilic esophagitis is a rising condition linked to increased allergic disorders, often presenting with symptoms like chronic dysphagia in young individuals.
  • A 29-year-old man experienced intermittent dysphagia for four years, supporting the typical symptoms of the condition, including a history of allergies and foreign body impaction.
  • Diagnosis requires systematic biopsies to check for more than 15 eosinophils per high power field, with treatment focusing on topical corticosteroids and addressing potential allergic triggers.

Article Abstract

Eosinophilic esophagitis is an unrecognized and emerging entity. Its incidence increases with allergic disorders. A 29-year-old man presented with a 4-year history of intermittent and paroxysmal dysphagia. The triad including allergy, young age, and impaction of foreign bodies, combined with a chronic dysphagia is almost pathognomonic of eosinophilic esophagitis. Endoscopic esophageal features can be diverse, so systematic esophageal biopsies are required. Diagnosis is established with the demonstration of an eosinophilic infiltrate with a cell count exceeding 15 eosinophils per high power field (×400). First line therapy includes swallowed topical corticosteroids and removal of an allergic cause, when it could be identified.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revmed.2009.12.017DOI Listing

Publication Analysis

Top Keywords

eosinophilic esophagitis
8
[eosinophilic esophagitis
4
esophagitis rare
4
rare dysphagia]
4
dysphagia] eosinophilic
4
esophagitis unrecognized
4
unrecognized emerging
4
emerging entity
4
entity incidence
4
incidence increases
4

Similar Publications

Interferon Signaling Alters Epithelial Function in Eosinophilic Esophagitis.

Cell Mol Gastroenterol Hepatol

January 2025

Department of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address:

View Article and Find Full Text PDF

Roads to remission: evolving treatment concepts in type 2 inflammatory diseases.

EClinicalMedicine

February 2025

Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, Marburg, Germany.

Unlabelled: Non-communicable diseases (NCDs) characterised by type 2 inflammation, including asthma, allergic rhinitis, chronic rhinosinusitis with nasal polyps, atopic dermatitis, food allergies and eosinophilic esophagitis, are increasing in prevalence worldwide. Currently, there is a major paradigm shift in the management of these diseases, towards the concept of disease modification and the treatment goal remission, regardless of severity and age. Remission as a treatment goal in chronic inflammatory NCDs was first introduced in rheumatoid arthritis, and then adopted in other non-type 2 inflammatory diseases.

View Article and Find Full Text PDF

Eosinophilic esophagitis is a chronic, antigen-driven, immune-mediated disease characterized by esophageal dysfunction and significant eosinophilic infiltration. Its rising incidence and prevalence over recent decades reflect both increased clinical awareness and the influence of environmental factors such as dietary patterns and allergen exposure. Among food allergens, cow's milk proteins are the most commonly implicated triggers, contributing to esophageal inflammation through complex immunological pathways involving both IgE-mediated and non-IgE-mediated mechanisms.

View Article and Find Full Text PDF

Eosinophilic esophagitis (EoE) is a chronic inflammatory esophageal disorder. The lack of non-invasive biomarkers currently results in dependency on endoscopy with biopsies for its diagnosis and monitoring. We aimed to identify potential non-invasive biomarkers using microRNAs (miRNAs) in plasma-derived extracellular vesicles (pEVs).

View Article and Find Full Text PDF

Comorbidity of Histamine Intolerance and Polyvalent Allergy: A Case Report and Literature Review.

Healthcare (Basel)

January 2025

Department of Prevention of Environmental Hazards Allergology and Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Histamine intolerance is becoming a critical medical problem across numerous clinical specialties, due to the absence of a standardized diagnostic and therapeutic strategy to manage patients with a suspicion of or diagnosis of this condition. Histamine intolerance is a type of non-immune food hypersensitivity, characterized by heterogenous etiologies and a very broad range of symptoms. The condition is the result of an imbalance between the amount of histamine accumulated within the body and the body's systemic ability to degrade it.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!